Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 570

University of Oxford

Illustrative: Then-US secretary of state John Kerry, speaking at the Oxford Union at Oxford University, England, May 11, 2016. (Peter Nicholls/Pool Photo via AP)
December 17, 2024, 4:06 pm
‘Toxic and polarizing’: Oxford Union debate on Israel genocide still roils
As counterterror police investigate an anti-Israel speaker’s statements at the November 28 event, Jewish students and panelists decry its contribution to climate of Jew-hatred
By Robert Philpot
Illustrative: Then-US secretary of state John Kerry, speaking at the Oxford Union at Oxford University, England, May 11, 2016. (Peter Nicholls/Pool Photo via AP)
November 25, 2024, 4:12 pm
Top UK university to debate if Israel is ‘an apartheid state responsible for genocide’
The exclusive Oxford Union society, which has hosted US presidents, celebrities and neo-Nazis, again courts controversy this week; its track record on Israel isn’t friendly
By Robert Philpot
A medic holds up a vial of the Pfizer-BioNTech COVID-19 coronavirus vaccine at a vaccination centre at the Atid al-Najah High School for the Sciences at the city of Taibeh in northern Israel on August 19, 2021. (JACK GUEZ / AFP)
August 19, 2021, 2:58 pm
Study finds Pfizer COVID-19 shots’ effectiveness drops faster than AstraZeneca’s
But Oxford University says research results suggest that after 4-5 months, the two vaccines would be similarly effective
By AFP
Maria Castro de Lima, 72, receives a dose of the Oxford-AstraZeneca COVID-19 vaccine from a healthcare worker, while sitting on the porch of her home in the Recanto community, along the Purus River, in the Labrea municipality, Amazonas state, Brazil, Feb. 12, 2021. (AP Photo/Edmar Barros)
March 18, 2021, 4:52 pm
UK study: Brazilian COVID strain may be less resistant to vaccines than feared
Researchers from University of Oxford say non-peer-reviewed data suggests natural and vaccine-induced antibodies can neutralize variants, but at lower levels
By ToI Staff
A health worker prepares doses of the AstraZeneca-Oxford COVID-19 vaccine on the first day of vaccination campaign, in Rabat, Morocco, Jan. 29, 2021 (AP Photo/Mosa'ab Elshamy)
February 13, 2021, 1:42 pm
AstraZeneca vaccine to be tested on children as young as 6 in world-first trial
University of Oxford announces plan to recruit 300 volunteers aged 6-17, with up to 240 receiving the COVID-19 vaccine and the remainder a control meningitis shot
By Agencies and ToI Staff
Illustrative: An image of a Symbicort budesonide inhaler for asthma. (Wikimedia Commons/One Salient Oversight)
February 11, 2021, 4:36 pm
Common asthma drug can reduce COVID hospitalizations by 90% — study
Oxford University researchers say steroid budesonide, inhaled as a treatment for respiratory disorders, effective when administered to patients within a week of first symptoms
By ToI Staff and AFP
This photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (John Cairns/University of Oxford via AP)
February 3, 2021, 12:17 pm
AstraZeneca vaccine cuts virus transmission by two-thirds after one dose – study
Non-peer-reviewed research by vaccine creator Oxford University is hailed by UK politicians as confirming strategy of waiting 12 weeks between doses
By AFP
Eden Amare Yitbarek, one of two Israeli winners of the prestigious 2021 Rhodes Scholarship to study at Oxford University. (Courtesy Eden Amare Yitbarek)
December 17, 2020, 8:32 pm
Israeli of Ethiopian origin one of 2 Rhodes scholars bound for Oxford
Eden Amare Yitbarek, 23, studied at Interdisciplinary Center Herzliya as part of special program sponsoring youngsters from the community with leadership potential for BA degrees
By Sue Surkes
This image made by the NASA/ESA Hubble Space Telescope shows M106 with additional information captured by amateur astronomers. (STScI/AURA), R. Gendler via AP)
December 4, 2020, 5:49 am
We’re all alone: Oxford study says chance of intelligent life elsewhere very low
Paper uses statistics to examine how long it took life to evolve on Earth and how likely each step was; concludes highly unlikely other intelligent civilizations out there
By ToI Staff
A researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University, November 23, 2020. (University of Oxford/John Cairns via AP, File)
November 26, 2020, 11:05 am
AstraZeneca facing questions about vaccine after admitting to testing error
Manufacturing glitch casts shadow on results of study after British drug group and Oxford university said lower dose of inoculation provides better protection from virus
By AP and ToI Staff
A sign is displayed outside Waterloo train station to remind people thy are required to wear face coverings inside the station and whilst travelling on trains during England's second coronavirus lockdown, in London, Friday, Nov. 20, 2020. Britain yesterday registered 501 daily COVID-19 deaths within 28 days of a positive test and is the fifth country in the world to record more than 50,000 coronavirus-related deaths. (AP Photo/Matt Dunham)
November 20, 2020, 4:19 pm
Study finds immunity after virus infection lasts at least 6 months
Oxford University report finds ‘good news,’ says examples of reinfection relatively rare and few cases found did not exhibit symptoms
By AFP
Laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina, August 14, 2020. (Natacha Pisarenko/AP)
October 22, 2020, 2:05 am
Volunteer in Oxford COVID vaccine test, given placebo, dies in Brazil
Death marks first known fatality in worldwide vaccine trials; independent review concludes no safety concerns and testing can continue
By AFP
A medical worker in the coronavirus ward of Soroka Medical Center in Beersheba on September 15, 2020. (Yossi Zeliger/Flash90)
September 16, 2020, 9:57 pm
Number of seriously ill virus patients surges as report points to excess deaths
While not explicitly attributing recent excess fatalities to COVID-19, Health Ministry says most of increase due to deaths among people above 65; record 551 in serious condition
By ToI Staff
Heather Lieberman (L), 28, receives a trial COVID-19 vaccination shot from Yaquelin De La Cruz at the Research Centers of America in Hollywood, Florida, on August 13, 2020. (Chandan Khanna/AFP)
September 12, 2020, 11:42 pm
Major COVID-19 vaccine trial resumes in UK following safety review
AstraZeneca and Oxford University say they got they all clear to continue inoculations after trials were briefly halted because volunteer became sick
By Jitendra Joshi
Illustrative: In this March 16, 2020 file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)
July 27, 2020, 4:27 pm
US virus vaccine put to final test in thousands of volunteers
Shot developed by NIH and Moderna to be tried on 30,000 people in coming months, with Israel among countries rooting for its success
By AP and ToI Staff
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.